Approval · Notice of Compliance 2444 · 2001
MUMPSVAX: Notice of Compliance 2444
Issued April 9, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2444
- Date
- April 9, 2001
- Company
- Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Kirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer name
- Therapeutic class
- Vaccine for immunization againts mumps
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MUMPSVAX | 00218677 | Cancelled Post Market |
Medicinal ingredients
- MUMPS VACCINE LIVE ATTENUATED 5,000 UNIT per 0.5ML